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Corona virus disease 2019 (COVID-19) is an infection 
caused by Severe Acute Respiratory Syndrome (SARS) 
CoV- 2 which is the seventh type belonging to the 
coronavirus family to affect human beings.1 The novel 
coronavirus (COVID-19) pandemic plaguing the entire 
world originated from Wuhan city, China in the month 
of December 2019.  This SARS-CoV-2 is a respiratory 
zoonotic disease having both bats and pangolins as the 
most probable origin and intermediate host.2,3 Initially, 
the identification and sequencing of the virus 
responsible for COVID-19 led to the conclusion that it is 
a novel Coronavirus (CoV) that shared an astonishing 
88% sequence identity with two bat-derived SARS-like 
CoV, suggesting its origin in bats.  
 
Further testing and full-length genome sequencing 
revealed that the 2019-nCoV shares 79.5% sequence 
identity with SARS-CoV; and consequently, protein 
sequence analysis divulged that the virus belonged to a 
class of SARS-related coronaviruses. The 2019-nCoV is 
believed to spread through close person-to-person 
contact of about 2 metres, a distance at which the 
respiratory droplets from an infected person either 
asymptomatic or symptomatic person (who coughs, 
sneezes, or speaks) can spread to other people who do 
not have adequate barriers (Proper distancing and 
masks). Another probable route of transmission occurs  
 
 
indirectly, when saliva droplets fall on other surfaces, 
such as the ground and objects made of different 
materials, and people come into contact with them.4 
COVID -19 has an incubation period of 1 to 15 days with 
most ranging from 3 to 7 days.5 Upon global protest, the 
World health Organization (WHO) declared COVID-19 
as a global  pandemic. 
 
SARS COV AND ACE INHIBITORS 
As with any infection, the entry of the virus in host cells 
is the first step in the initiation of the infection;  with 
the presence of a spike glycoprotein on the viral 
envelope of the coronavirus binding to specific 
receptors on the membrane of host cells. Laboratory 
based studies have documented that ACE2 is the specific 
functional receptor for SARS-CoV. It was further 
revealed that this virus can enter ACE2 expressing cells, 
as the virus did not affect cells without ACE2 receptors 
or other cells expressing coronavirus receptors [which 
include aminopeptidase N and dipeptidyl peptidase 4 
(DPP4)].6,7 
 
The receptor-binding domain of the spike glycoprotein 
was reported to bind itself to the tip of subdomain I of 
ACE2. The fusion of the virus to the  cell membrane of 
the host cell is activated after binding, which leads to 
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cytoplasm, and thus manifesting infection. In this 
process, a few transmembrane proteinases [disintegrin 
and metallopeptidase domain 17 (ADAM17) 
particularly], transmembrane protease serine 2 
(TMPRSS2)], TNF-converting enzyme and proteins 
(which include vimentin and clathrin) are documented 
to be involved in the processes of binding and 
membrane fusion. 
 
The ACE2 receptor is expressed in differing degrees in 
all human organs and in the respiratory system, it is 
mainly expressed in the type II alveolar epithelial cells 
of the oral and nasal mucosa and nasopharynx, 
indicating that the lungs are in fact the primary target of 
SARS viruses. In addition, the ACE2 receptor is also 
reported to be highly expressed in myocardial cells, 
proximal tubule cells of the kidney, the urothelial cells 
of the bladder, and abundantly expressed on the 
enterocytes of the small intestine. The virus, which is 
cell-free, and is macrophage phagocytosis-associated 
might possibly spread from the lungs to other vital 
organs with a high ACE2 expression through blood 
circulation. Figure 1 depicts the diagrammatic 







ACE-2  was  expressed   in   the   oral  cavity  more 
prominently  in  epithelial  cells  of   the   tongue        as   
compared to other oral sites such as gingival and buccal 
mucosa.8 In clinical studies, it was found to be strongly 
expressed in taste buds of rats. Furthermore,  
angiotensin II produced in taste buds of mice 
demonstrated an essential role altering taste sensitivity. 
Since ACE2 is found to degrade the Ang II receptors, 
which might lead to possible accumulation of Ang II in 
taste buds during COVID-19 infection and this 
mechanism possibly explains the reason behind the 
reported dysgeusia among patients.  
 
CNS INVASION6 






MECHANISM OF SARS-CoV-2 IN ORAL 
CAVITY7 
The mechanism of action of SARS-CoV-2 on the 
oral cavity is shown in figure 3. 
 
ORAL MANIFESTATIONS OF SARS-CoV-2 
Olfactory Dysfunction: According to Biadsee et 
(2020)8, 67% of patients report olfactory dysfunction 
during the disease. These olfactory impairments can be 
classified into two main categories: the first being 
conductive losses stemming from obstruction of nasal 
passages and the second: sensorinueral causes from 
damage to the olfactory nueroepithelium which are 
most often attributed to post viral olfactory loss. 
 
Ulceration in The Oral Cavity: According to a review 
by Behzad et al., oral manifestations of patients affected  
 
Figure 1. Diagrammatic Representation of 
Virus Attaching to Host Cell 
Figure 2. CNS Invasion of SARS-COV-2 
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with COVID-19    included   ulcer,  erosion, bulla, vesicle,  
pustule, fissured or depapillated tongue, macule, 
papule, plaque, pigmentation, halitosis, whitish areas, 
hemorrhagic crust, necrosis, petechiae, swelling, 
erythema, and spontaneous bleeding. The most 
common sites  of involvement in descending order were 
tongue (38%), labial mucosa(26%), palate (22%), gingiva 
(8%), buccal mucosa (5%), oropharynx (4%),and tonsil 
(1%). Suggested diagnoses of the lesions were aphthous 
stomatitis, herpetiform lesions, candidiasis, vasculitis, 
Kawasaki-like, EM like mucositis, drug eruption, 
necrotizing periodontal disease, bullosa-like, angular 
cheilitis, atypical Sweet syndrome, and Melkerson-
Rosenthal syndrome. The oral lesions in approximately 
68% of the patients were reported to be symptomatic 
(painful, burning sensation, or pruritus) and were nearly 
equally distributed among both genders (49% female, 
51% male). The latent time between appearance of oral 
lesions was between 4 days before and up to 12 weeks 
after the onset of systemic symptoms among patients.9 
 
Biadsee and colleagues demonstrated that 7% of the 
patients with RT-PCR positive test had plaque-like 
changes on the dorsum of tongue. Also, swelling of oral 
cavity including palatal, lingual, and gum) was reported 
by 8% of the patients. In addition, the appearance of oral 
lesions was simultaneously observed with a loss of taste  
and smell in patients with more severe and 
disseminated oral lesions reported among older 
patients.8  
 
Stress and immunosuppression associated with COVID-
19 and drug eruption, vasculitis, or thrombotic 
vasculopathy secondary to COVID-19 were suggested as 
causes for development of ulcerative and erosive lesions 
and appearance of secondary herpetic gingivostomatitis. 
Oral lesions also included a painful, diffuse 
erythematous  gingiva with necrosis of inter-papillary 
areas which suggested diagnosis of  necrotizing 
periodontal disease as a result of bacterial co-infections. 
The lesions recovered after 5 days.9 
  
Taste: Among patients, a true loss of taste is extremely 
rare, and is routinely preceded by the inability to 
perceive the odor of food due to olfactory dysfunction.10 
Biadsee et al. reported that 25.8% patients with an 
impaired sense of smell and taste in the absence of other 
symptoms. The pooled eligible data for different taste 
disorders were 38% for dysgeusia, 35% for hypogeusia 
while ageusia had a prevalence of 24%. A loss of smell or 
taste as a result of COVID-19 seems to last slightly longer 
as compared to various other upper respiratory 
infections. The median reported duration of loss of 
smell or taste among patients suffering from COVID-19 
was 8 days. 
 
Dry Mouth: There is a strong correlation found 
between burning mouth and alteration of taste. Since 
saliva functions as a solvent of taste and regulates the 
conditions of taste receptors, a change in the salivary 
flow can be potentially linked to an altered taste 
alteration among patients. Taste disorders involve the 
damage of gustatory papillae and taste buds caused by 
reduced saliva secretion. Since human salivary glands 
express ACE2 and TMPRSS2, salivary gland infection 
with SARS-CoV-2 would affect saliva secretion, thereby 
altering the tasting ability.11 
 
The element zinc has been reported to increase the 
secretion of unstimulated and stimulated saliva in  
humans, and its deficiency is associated with COVID-19 
as it may induce gustatory dysfunction through 
hyposalivation. The important functions of zinc not only 
include building the immune system and inflammatory 
response, but also involves the gustatory function at a 
level of taste buds and taste stimulus-transmitting 
nerves.  It is also required for the subsequent 
regeneration and maintenance of taste cells and for 
zinc-metalloenzymes  localized   in   taste   buds.  Taste  
Figure 3. Mechanism of Action of  SARS-
COV-2 in Oral Cavity  
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disorders are improved by administrating zinc as zinc 
ionophore chloroquine  which increases the cellular 
influx of zinc that inhibits SARS-CoV-2.  A   decreased 
zinc level is also favorable for the interaction of zinc-
dependent metalloenzyme ACE2 with spike proteins of 
SARS-CoV-2 but an increased zinc level inhibits ACE2 
expression.12 
 
Periodontal Tissue: Among periodontal tissues,  
ACE2, TMPRSS2, and furin have been documented to 
play an important  and have an established role in the 
viral cell invasion and are expressed in the epithelium of 
the gingival sulcus and periodontal pocket. Hence, the 
virus potentially infects these epithelia and leads to a 
potentially adverse effect on periodontal tissues. The 
major periodontopathic bacteria Prevotella intermedia 
has been frequently detected among COVID-19 patients. 
On subsequent examination, the intraoral cavity of 
patients revelaed severe halitosis, generalized 
erythematous, edematous gingivae, and necrotic 
papillae (interdental) in both the maxillary and 
mandibular sextants on the labial side.13 
 
Inflammation of Salivary Glands: Cases involving 
inflamed salivary glands have been reported among 
COVID-19 patients due to the expression of ACE2 in 
these glands. The virus can cause acute sialadenitis by 
binding to ACE2 receptors in the epithelia of the salivary 
glands and lead to lysing of the cells.11 The inflammatory 
damages to the acinar cells are subsequently repaired by 
fibroblast proliferation and fibrous connective tissue 
formation, this fibrous repair and hyperplasia may give 
rise to salivary gland hyposecretion and ductal stenosis, 
as a result of which, the salivary flow is reduced.14 
 
CONCLUSION 
SARS-CoV-2 may manifest with various combinations of 
symptoms. Aphthous-like lesions, gustatory 
disturbance, candidiasis, xerostomia and oral lesions of 
Kawasaki-like disease are the most common oral 
manifestations of COVID-19 disease. Lack of oral 
hygiene, opportunistic infections, stress, underlying 
diseases (diabetes mellitus, immunosuppression), 
trauma (secondary to intubation), vascular 
compromise, and hyper-inflammatory response 
secondary to COVID-19 might be  the most important 
predisposing factors for the development of oral lesions 
in COVID-19 patients. 
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